Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries
about
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignHuman monoclonal antibody-based therapy in the treatment of invasive candidiasisNeutralizing antibody response to hepatitis C virusMonoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinDiverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV PseudotypeIdentification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 ProteinIn vitro selection of a neutralization-resistant hepatitis C virus escape mutantMutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityHepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral GenotypesIdentification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C VirusHuman monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateBacteriophages and Their Immunological Applications against Infectious Threats.Identification of a conserved JEV serocomplex B-cell epitope by screening a phage-display peptide library with a mAb generated against West Nile virus capsid proteinBroadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide libraryDevelopment of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations.Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.Multiantibody strategies for HIV.HCV E2 core structures and mAbs: something is still missing.Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
P2860
Q26801759-E67250DE-011E-43D5-9EF6-0CE56E042598Q26864291-0CFDFD18-03A4-4C0D-AA9F-D108A7EE9D43Q27027484-8E27A349-56C6-4CFE-91D5-1881E6E1EAC6Q27470798-7310E656-717C-4E63-9FE7-2C841F291A00Q27472930-D41EF700-7758-481E-98A8-118A0DE88A65Q27485318-3AB7D376-8ACB-4529-A862-A16363208F80Q27487549-E092AD85-374E-44EF-BD2C-4A39715ADC1FQ27488430-5618654C-E6A5-43F3-95AF-60922CBFDF7DQ27490450-956FF950-2D06-46C9-9721-24ED79BF8350Q27490467-043348F6-8F58-404E-BFEA-11A370C4604EQ28482261-E4548DCC-4EDB-4507-817B-7A0719B58F8BQ30234522-0401FF57-C49A-4E7B-BD08-84DF4D9025CDQ33837481-200760C0-CE96-435C-BF06-0592E1A5103FQ33913588-37E5D140-1646-4261-81EA-1B7FBF2B893AQ33951093-4E0F30EA-6B54-4D13-9004-D13259EF5634Q34291876-8E3C3E2B-3907-4A6C-92B1-603C8C6C6E8CQ34864567-AB3E6745-7385-49BD-9720-6E1215029907Q35274913-DEBCCD79-5957-4356-A8AC-440074DB058FQ36404194-2C7B65EC-9B61-4A7F-BE4E-4A35839CA246Q36432725-F2C73C28-3DFB-4953-83E1-F6D642EB380BQ36432748-6A603658-3B24-4962-9329-140E6F7C5CCFQ36682313-353D39BB-1160-47F6-A938-17CFAAD85D33Q38120526-6C289538-8322-4674-8AFD-46F44322D457Q38244787-B0E2BF24-F807-4791-A284-0D6DF085E28DQ42981429-0323E140-05D3-4615-9BCB-26BDB1D2473B
P2860
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mapping B-Cell Epitopes of Hep ...... s from Phage Display Libraries
@nl
Mapping B-cell epitopes of hep ...... s from phage display libraries
@ast
Mapping B-cell epitopes of hep ...... s from phage display libraries
@en
type
label
Mapping B-Cell Epitopes of Hep ...... s from Phage Display Libraries
@nl
Mapping B-cell epitopes of hep ...... s from phage display libraries
@ast
Mapping B-cell epitopes of hep ...... s from phage display libraries
@en
prefLabel
Mapping B-Cell Epitopes of Hep ...... s from Phage Display Libraries
@nl
Mapping B-cell epitopes of hep ...... s from phage display libraries
@ast
Mapping B-cell epitopes of hep ...... s from phage display libraries
@en
P2093
P2860
P50
P921
P1433
P1476
Mapping B-cell epitopes of hep ...... s from phage display libraries
@en
P2093
A Gabrielli
A Gasbarrini
C Di Campli
P2860
P304
P356
10.1128/JVI.75.20.9986-9990.2001
P577
2001-10-01T00:00:00Z